Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics

JAMA. 2020 May 19;323(19):1897-1898. doi: 10.1001/jama.2020.4742.
No abstract available

MeSH terms

  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use
  • Betacoronavirus*
  • COVID-19
  • Compassionate Use Trials*
  • Coronavirus Infections / drug therapy*
  • Hemorrhagic Fever, Ebola / drug therapy
  • Humans
  • Off-Label Use*
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Randomized Controlled Trials as Topic*
  • SARS-CoV-2

Substances

  • Antiviral Agents

Supplementary concepts

  • COVID-19 drug treatment